Skip to content
Screener

Arrowhead Research ARWR Interest Expense

Interest Expense at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$4.62M+12.3%
ALN
Alnylam PharmaceuticalsALNY
$82.05M+104%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$17K-39.3%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$4.2M
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$12.94M-28.6%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$4.58M-15.3%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025Six Months Ended March 31, 2026Six Months Ended March 31, 2025
Operating (loss) income(141,260)381,202(100,451)219,790
Other income (expense):
Interest income16,8699,61526,56017,217
Interest expense(23,846)(21,639)(46,351)(43,285)
Loss on equity method investment(6,719)(6,719)
Gain on VIE's sale of IPR&D assets19,00019,000
Other, net(1,609)438(1,332)779
Total other income (expense)3,695(11,586)(8,842)(25,289)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's interest expense?
Arrowhead Research (ARWR) reported interest expense of $23.85M in Q1 2026.
How has Arrowhead Research's interest expense changed year-over-year?
Arrowhead Research's interest expense increased by 10.2% year-over-year, from $21.64M to $23.85M.
What is the long-term trend for Arrowhead Research's interest expense?
Over 4 years (2021 to 2025), Arrowhead Research's interest expense has grown at a 1629.0% compound annual growth rate (CAGR), from $1K to $89.36M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about Arrowhead Research's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude